Literature DB >> 229176

Indirect immunofluorescence test for detection of IgM antibodies to cytomegalovirus.

A C Hekker, B Brand-Saathof, J Vis, R C Meijers.   

Abstract

A technique for the detection of IgM antibodies to cytomegalovirus (CMV) by immunofluorescence was developed. In order to prevent interference by rheumatoid factor in the sera, IgG was removed by prior immunoabsorption with antiserum to gamma Fc. Sera from 63 patients with a rise in titer of antibody to CMV, indicated by complement fixation, were IgM-positive, but yielded negative results on the Paul-Bunnell-Davidsohn test for infectious mononucleosis. Convalescent-phase serum samples from 20 patients with a seroconversion to herpes simplex virus and from 20 patients with a seroconversion to varicella-zoster virus also had no IgM antibodies to CMV. Sera from six of 10 patients with infectious mononucleosis and two of 100 normal blood donors were positive for IgM antibodies to CMV. In 38 of 63 patients, the diagnosis of CMV infection could be made several weeks earlier by the immunofluorescence test than by the complement-fixation test. IgM antibodies to CMV persisted for more than two months after onset of symptoms of the infection.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229176     DOI: 10.1093/infdis/140.4.596

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Case of the month: a newborn with tachypnoea and consolidation of the right lung.

Authors:  A Karperien; J N van den Anker; P H Rothbarth; R de Groot
Journal:  Eur J Pediatr       Date:  1996-09       Impact factor: 3.183

2.  Detection of specific immunoglobulin M antibodies to cytomegalovirus by using monoclonal antibody to immunoglobulin M in an indirect immunofluorescence assay.

Authors:  M Zerbini; M Musiani; G Gentilomi; M La Placa
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

3.  Acute respiratory insufficiency from psittacosis.

Authors:  M van Berkel; H Dik; J W van der Meer; J Versteeg
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

4.  Sensitivity and specificity of viral immunoglobulin M determination by indirect enzyme-linked immunosorbent assay.

Authors:  H Champsaur; M Fattal-German; R Arranhado
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

5.  Enzyme-linked immunosorbent assay that uses labeled antigen for detection of immunoglobulin M and A antibodies in toxoplasmosis: comparison with indirect immunofluorescence and double-sandwich enzyme-linked immunosorbent assay.

Authors:  A M van Loon; J T van der Logt; F W Heessen; J van der Veen
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

6.  [Diagnosis of cytomegalovirus infections in newborn infants and infants: the value of indirect immunofluorescence compared with complement fixation and virus isolation].

Authors:  R Gibert; M Aymard; M Langlois
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

7.  Detection of virus-specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection by enzymeimmuno and radioimmunoassay techniques.

Authors:  I Sarov; E Levy; M Aymard; Y Chardonnet; S Bosshard; J P Revillard; M Friedman; E Nord; M Greiff; H Haikin
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

8.  Serological Investigation of the possibility of congenital transmission of papovavirus JC.

Authors:  R Daniel; K Shah; D Madden; S Stagno
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

9.  Serological investigation of BK papovavirus infection in pregnant women and their offspring.

Authors:  K Shah; R Daniel; D Madden; S Stagno
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

10.  Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience.

Authors:  A H Balk; W Weimar; P H Rothbarth; K Meeter; H J Metselaar; B Mochtar; M L Simoons
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.